A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

The US FDA has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...

Jan. 13, 2025 — A new study found no changes in opioid outcomes among the general population with the states' passage of medical and recreational marijuana laws. However, the findings also show ...

US FDA has approved its first ever non-opioid painkiller called suzetrigine. Experts believe it will prevent addiction ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

A new non-opioid painkiller, suzetrigine , has just been approved by the US drug regulator, the FDA. It is the first non-opioid painkiller the agency ...

One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...